Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors

Oncogene

Volumn 22, Issue 14, 2003, Pages 2121-2134

  Ahonen, Matti ^a   Poukkula, Minna ^a   Baker, Andrew H ^b   Kashiwagi, Masahide ^c   Nagase, Hideaki ^c   Eriksson, John E ^a   Kähäri, Veli Matti ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Caspase; Death receptor; Melanoma; TIMP 3

Indexed keywords

ADAMALYSIN; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 8; CASPASE INHIBITOR; FAS ANTIBODY; FAS LIGAND; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; RECOMBINANT PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ADENOVIRUS; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; CASPASE 8; CASPASE 9; CASPASES; HUMANS; MELANOMA; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

ADENOVIRIDAE;

EID: 0038297557     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206292     Document Type: Article

References (54)

1. Ahonen M, Ala-aho R, Baker AH, George S J, Grénman R, Saarialho-Kere and Kähäri V-M. (2002) Mol. Ther., 6, 705-715.
2. Ahonen M, Baker AH and Kähäri V-M. (1998). Cancer Res., 58, 2310-2315.
3. Amour A, Knight CG, Webster A, Slocombe PM, Stephens PE, Knäuper V, Docherty AJ and Murphy G. (2000). FEBS Lett., 473, 275-279.
4. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knäuper V, Docherty AJ and Murphy G. (1998). FEBS Lett., 435, 39-44.
5. Ashkenazi A and Dixit VM. (1999). Curr. Opin. Cell. Biol., 2, 255-260.
6. Bachman KE, Herman JG, Corn PG, Merlo A, Costello JF, Cavenee WK, Baylin SB and Graft JR. (1999). Cancer Res., 59, 798-802.
7. Baker AH, George SJ, Zaltsman AB, Murphy G and Newby AC. (1999). Br. J. Cancer, 79, 1347-1355.
8. Baker AH, Wilkinson GWG, Hembry RM, Murphy G and Newby AC. (1996). Matrix Biol., 15, 383-395.
9. Baker AH, Zaltsman AB, George SJ and Newby AC. (1998) J. Clin. Invest., 101, 1478-1487.
10. Boldin MP, Goncharov TM, Goltsev YV and Wallach D. (1996). Cell, 85, 803-815.
11. Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y, Camonis JH and Wallach D. (1995). J. Biol. Chem., 270, 387-391.
12. Bond M, Murphy G, Bennett MR, Amour A. Knäuper V, Newby AC and Baker AH. (2000) J. Biol. Chem., 275, 41358-41363.
13. Bond M, Murphy G, Bennett MR, Newby AC and Baker AH. (2002) J. Biol. Chem., 277, 13787-13795.
14. Borland G, Murphy G and Ager A. (1999). J. Biol. Chem., 274, 2810-2815.
15. Brew K, Dinakarpandian D and Nagase H. (2000). Biochim. Biophys. Acta, 1477, 267-278.
16. Chan K-M C, Chun HJ, Zheng L, Siegel RM, Bui KL and Lenardo MJ. (2000). Science, 288, 2351-2354.
17. Chirivi RG, Garofalo A, Crimmin MJ, Bawden LJ, Stoppacciaro A, Brown PD and Giavazzi R. (1994). Int. J. Cancer, 58, 460-464.
18. Cohen GM. (1997). Biochem. J., 326, 1-16.
19. Ekmekcioglu S, Okcu MF, Colome-Grimmer MI, Owen-Schaub L, Buzaid AC and Grimm EA. (1999). Melanoma Res., 9, 261-272.
20. Fata JE, Leco KJ, Voura EB, Yu HY, Waterhouse P, Murphy G, Moorehead RA and Khokha R. (2001). J. Clin. Invest., 108, 799-800.
21. Fariss RN, Apte SS, Olsen BR, Iwata K and Milham AH. (1997). Am. J. Pathol., 150, 323-328.
22. Fitzgerald ML, Wang Z, Park PW, Murphy G and Bernfield M. (2000). J. Cell. Biol., 148, 811-824.
23. Hargreaves PG, Wang F, Antcliff J, Murphy G, Lawry J, Russell RG and Croucher PI. (1998). Br. J. Haematol., 101, 694-702.
24. Herr I and Debatin KM. (2001). Blood, 98, 2603-2614.
25. Hsu H, Shu HB, Pan MG and Goeddel DV. (1996). Cell, 84, 299-308.
26. Kashiwagi M, Tortorella M, Nagase H and Brew K. (2001). J. Biol. Chem., 276, 12501-12504.
27. Killar L, White J, Black R and Peschon J. (1999). Ann. NY Acad. Sci., 878, 442-452.
28. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ and Ashkenazi A. (2000). Immunity, 6, 611-620.
29. Langton KP, Barker MD and McKie N. (1998) J. Biol. Chem., 273, 16778-16781.
30. Leco KJ, Khokha R, Pavloff N, Hawkes SP and Edwards DR. (1994) J. Biol. Chem., 269, 9352-9360.
31. Lehti K, Lohi J, Valtanen H and Keski-Oja J. (1998). Biochem J., 334, 345-353.
32. Loging WT and Reisman D. (1999). Oncogene, 18, 7608-7615.
33. Mitsiades N, Poulaki V, Leone A and Tsokos MJ. (1999). J. Natl. Cancer. Inst., 91, 1678-1684.
34. Mitsiades N, Yu WH, Poulaki V, Tsokos M and Stamenkovic I. (2001). Cancer Res., 61, 577-581.
35. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM. (1996). Cell, 85, 817-827.
36. Nagata S and Golstein P. (1995). Science, 267, 1449-1456.
37. O'Connell J, Bennett MW, O'Sullivan GC, Collins JK and Shanahan F. (1999). Immunol. Today, 20, 46-52.
38. Owen-Schaub LB, Golen KL, Hill LL and Price JE. (1998). J. Exp. Med., 188, 711-718.
39. Pavloff N, Staskus PW, Kishnani NS and Hawkes SP. (1992) J. Biol. Chem., 267, 17321-17326.
40. Pennie WD, Hegamyer GA, Young MR and Colburn NH. (1999). Cell. Growth Differ., 10, 279-286.
41. Schlöndorff J and Blobel CP. (1999). J. Cell Sci., 112, 3603-3617.
42. Smith MR, Kung H, Durum SK, Colburn NH and Sun Y. (1997). Cytokine, 9, 770-780.
43. Solomon KA, Pesti N, Wu G and Newton RC. (1999). J. Immunol., 163, 4105-4108.
44. Soubrane C, Mouawad R, Antoine EC, Verola O, Gil-Delgado M and Khayat D. (2000). Br. J. Dermatol., 143, 307-312.
45. Sternlicht MD and Werb Z. (2001). Annu. Rev. Cell Dev. Biol., 17, 463-516.
46. Terheyden P, Siedel C, Merkel A, Kampgen E, Brocker EB and Becker JC. (1999). J. Invest. Dermatol., 112, 899-902.
47. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM. (1995). Cell, 81, 801-809.
48. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH and Goggins M. (2000). Cancer Res., 60, 1835-1839.
49. Ugurel S, Rappl G, Tilgen W and Reinhold U. (2001). Clin. Cancer Res., 7, 1108-1109.
50. Wehrli P, Viard I, Bullan R, Tschopp J and French LE. (2000) J. Invest. Dermatol., 115, 141-148.
51. Westermarck J and Kähäri VM. (1999). FASEB J., 13, 781-792.
52. Wilkinson GWG and Akrigg A. (1992). Nucleic Acids Res., 20, 2233-2239.
53. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV and Mak TW. (1998). Science, 279, 1954-1958.
54. Yu WH, Yu SS, Meng Q, Brew K and Woessner Jr JF. (2000). J. Biol. Chem., 275, 31226-31232.